「and areductionin」の検索結果
114件：101～105件目を表示
もしかして
-
arept® Ophthalmic Suspension 0.3%” (Generic Name: Motugivatrep; hereinafter: Avarept® ), discovered and licensed from Mochida Pharmaceutical Co., Ltd. (Headquarters: Tokyo, Japan; President: Mr. Naoyu...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406.pdf -
arept® Ophthalmic Suspension 0.3%” (Generic Name: Motugivatrep; hereinafter: Avarept® ), discovered and licensed from Mochida Pharmaceutical Co., Ltd. (Headquarters: Tokyo, Japan; President: Mr. Naoyu...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406_0.pdf -
Announcement Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Ey...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
Announcement Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Ey...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222.pdf -
Management Policy | About Senju | SENJU Pharmaceutical
“Being a good company” is our management policy. As a company that aims to be reliable, necessary and valuable for society, we are committed to pursuing happiness for all people associated with Senju ...
http://www.senju.co.jp/english/about/philosophy.html